Using Urine to Study Antibodies & Functional Cell-Mediated Immunity in the Context of Chlamydia Trachomatis
NCT07596316 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 73
Last updated 2026-05-19
Summary
The goal of this observational study is to learn if we can identify immune biomarkers in first-void urine and vaginal brush samples in Chlamydia trachomatis (CT) positive adult women. Participants will self-collect a first-void urine sample, self-collect a vaginal brush, and a blood sample will be collected by a healthcare worker. Participants will complete a questionnaire.
Conditions
- Chlamydia Trachomatis Genital Infection
Interventions
- DEVICE
-
Sampling
Collection of first-void urine (i.e. the initial stream of urine) with the Colli-Pee device (Novosanis, Belgium) (one sample of approx. 20 mL). Collection of a vaginal brush sample with the Evalyn brush (Rovers Medical Devices, The Netherlands). Collection of blood samples (three blood tubes of approx. 9 mL).
Sponsors & Collaborators
-
Violett Antwerp
collaborator UNKNOWN -
Universiteit Antwerpen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-10
- Primary Completion
- 2027-06-30
- Completion
- 2027-06-30
Countries
- Belgium
Study Locations
More Related Trials
-
Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract
NCT00578188 ·Status: WITHDRAWN
-
CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency
NCT07015801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cytomegalovirus Infection in Patients With HIV-1 Infection
NCT04067869 ·Status: COMPLETED ·Phase: PHASE3
-
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
NCT04453280 ·Status: COMPLETED
-
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
NCT04469634 ·Status: COMPLETED ·Phase: NA
-
Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV
NCT02798692 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine
NCT01357915 ·Status: COMPLETED ·Phase: NA
-
The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
NCT01081379 ·Status: UNKNOWN
-
Universal Screening Program for Cytomegalovirus Infection in the First Trimester of Pregnancy (CITEMB Study)
NCT05699421 ·Status: COMPLETED
-
Measuring Responses to Sublingual Antigens
NCT00949572 ·Status: COMPLETED ·Phase: NA
-
Detection of Cytomegalovirus Virus in Neonates
NCT03251261 ·Status: COMPLETED
-
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
NCT01753167 ·Status: COMPLETED ·Phase: PHASE2
-
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
NCT06379061 ·Status: COMPLETED
-
Cell-mediated Immunity for Prevention of CMV Disease
NCT02538172 ·Status: COMPLETED ·Phase: NA
-
Monoclonal Antibody-based Multipurpose Microbicides
NCT01859195 ·Status: COMPLETED
-
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
NCT05170269 ·Status: TERMINATED ·Phase: PHASE3
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Artus® CMV PCR Test
NCT01034709 ·Status: COMPLETED
-
PREDICT Cytomegalovirus (CMV)
NCT03300882 ·Status: COMPLETED
-
Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
NCT04392297 ·Status: COMPLETED
-
Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region
NCT07387211 ·Status: COMPLETED ·Phase: NA
-
Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM
NCT00370006 ·Status: COMPLETED ·Phase: PHASE1
-
CMV IGG Antibodies in Semen as a Predictor for Blood Testis Barrier Damage
NCT05302856 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
NCT01659684 ·Status: UNKNOWN ·Phase: NA
-
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
NCT06494033 ·Status: RECRUITING